OMB# 0925-0766
Exp. 4/30/2023
Public reporting burden for this collection of information is estimated to average 60 minutes per
response, including the time for reviewing instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the collection of information. An agency may
not conduct or sponsor, and a person is not required to respond to, a collection of information unless it
displays a currently valid OMB control number. Send comments regarding this burden estimate or any
other aspect of this collection of information, including suggestions for reducing this burden, to: NIH,
Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA
(0925-0766). Do not return the completed form to this address.
COPD National Action Plan Collaboration and Tracking System — Preliminary Model
Please share your activity or initiative in support of the National Action Plan. Report only one activity per form submission.
Name
of the
activity
Name
Organization
(for this activity)
Role in organization
City/Town
State/Province
Email Address
Phone Number
Which best describes you or your organization?
Advocacy organization/non-profit Health professional organization Health care provider
Industry
Federal, state, or local government agency Academic institution
Policymaker
Other (please describe)
Briefly describe your activity and how it contributes to the goals and objectives of the COPD National Action Plan.
Summary
(max 1500
characters)
Include
any links where people can learn
more
(websites, social media, journal articles, etc.).
Which goal of the National Action Plan does this activity best align with? While an organization might address multiple goals, each individual activity usually focuses most strongly on one. If this activity has a strong focus on more than one goal, please choose a primary and up to two secondary goals.
|
Primary |
|
Secondary |
1: Empower people with COPD, their families, and caregivers to recognize and reduce the burden of COPD. |
|
|
|
2: Improve the prevention, diagnosis, treatment, and management of COPD by improving the quality of care delivered across the health care continuum. |
|
|
|
3: Collect, analyze, report, and disseminate COPD-related public health data that drive change and track progress. |
|
|
|
4: Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD. |
|
|
|
5: Translate national policy, educational, and program recommendations into research and public health care actions. |
|
|
|
Items 7-11 list objectives of each goal.
Please select only objectives corresponding to the goal(s) you
selected above, then continue on page 5.
Increase public awareness of the risk factors and symptoms of COPD so that earlier diagnosis of symptomatic individuals becomes the norm
Increase the effectiveness and variety of outreach communication campaigns and activities that utilize evidence-based approaches to raise awareness of COPD, particularly among those at high risk, and help people diagnosed with COPD manage the disease
Expand opportunities to increase COPD awareness across the public-private spectrum
Develop, disseminate, and maintain unified, multidisciplinary, and patient-centric national guidelines for COPD that are accessible and easy to follow
Develop a unified, multidisciplinary educational curriculum for health care professionals, including primary health care providers, using harmonized clinical practice guidelines
Develop, in accordance with clinical quality measures, a clinical decision tree and other tools to enable high-quality care for people with COPD
Develop and encourage the use of a written, patient-centric COPD management plan tool, with appropriate cultural and health literacy considerations, which can be customized with input from the patient's health care provider(s)
Improve access to care for people with COPD, particularly for those in hard-to reach areas
Enhance and optimize our capacity to collect and aggregate data from multiple sources, including at local, regional, and national levels, and turn them into actionable information.
Facilitate dissemination of data and analyses. Report the prevalence of COPD in accordance with the requirements of public health and health care organizations
Help expand, coordinate, and optimize COPD research efforts
Improve methods for earliest detection and diagnosis and develop effective strategies for preventing the onset and progression of COPD
Define and characterize the pathogenesis of COPD heterogeneity
Develop personalized medicine for COPD based on the pathogenesis and clinical heterogeneity
Promote research that can lead to strategies that help prevent the onset and progression of COPD and improve the quality of COPD care and management
Put into action prevention strategies that are proven effective in addressing the 80 percent of COPD deaths due to smoking
Create a collaborative official entity that implements, prioritizes, and tracks activities in accordance with the COPD National Action Plan's goals and objectives
Identify and publicize funding opportunities that advance the implementation of the COPD National Action Plan Develop and implement COPD quality measures into national care delivery
Strengthen the public health infrastructure for addressing COPD
Patients
Caregivers, family members
At-risk populations (history of smoking, workplace exposure to lung irritants, alpha-1 antitrypsin deficiency)
General public
Other (please describe)
Health professionals Employers Researchers Policymakers
|
Hispanic |
|
Men |
|
Non-Hispanic American Indian or Alaska Native |
|
Women |
|
Non-Hispanic Asian or Pacific Islander |
|
|
|
Non-Hispanic Black |
|
|
|
Non-Hispanic White
|
|
Other (please describe below) |
|
|
|
|
Patient education
Event
Campaign
Healthcare delivery
Material or product (indicate type — print, audio, visual, etc. — under other)
Provider education
Research Service Support group Training
Other (please describe)
When
did it
start? (Month and
year)
When did it stop, or is it ongoing?
Ongoing
Stop date (Month and year)
What area(s) of the country does your activity cover?
Geographic location (Choose all that apply) 18. Type of area (Choose all that apply)
|
National |
|
Urban |
|
Regional (multi-state; indicate states: _________________________________) |
|
Suburban |
|
State (indicate state: ________________) |
|
Rural |
|
Local (indicate state: ________________) |
|
|
|
Other (please describe below) |
|
|
|
|
|
|
Community Health care Home
Workplace Online
Other (please specify)
We worked alone
We worked with the following organization(s) or individual(s)
Please describe how much this activity cost and its funding sources.
What impact has your activity had so far? (Include quantitative data if available, such as analytics, number of attendees or enrollees, quantities distributed or downloaded, etc.)
What
advice or lessons learned do you have for anyone considering a
similar activity?
What
role
did
the
COPD
National
Action
Plan
play
in
helping
you
develop
the
activity
(e.g., provide
ideas, lead to new collaborations or funding,
etc.)?
Yes No
Draft
— February 6, 2020
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | View Survey |
Author | Ammary-Risch, Neyal (NIH/NHLBI) [E] |
File Modified | 0000-00-00 |
File Created | 2021-10-04 |